Clinical Trials Directory

Trials / Completed

CompletedNCT02273323

Flow Mediated Dilation in Response to Black Tea

Flow Mediated Dilation in Response to Consumption of Black Tea Versus Artificial Tea, in Non-tea Drinking Hypertensive Subjects.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Unilever R&D · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Research indicate that people who regularly drink tea have a reduced risk of stroke or heart disease. In a number of studies in which people that normally do not drink showed that their blood vessels function improved when the drunk tea. The current study tests whether a specific black tea improves vessel function in non-tea drinking hypertensive subjects.

Detailed description

Epidemiological studies indicate that regular consumption of three cups of black tea per day reduces the risk of stroke or myocardial infarction. In a number of previous nutrition intervention studies tea has been shown to improve vascular function as assessed by Flow Mediated Dilation in various populations. The current confirmatory study tests a specific black tea against a placebo in a population of in non-tea drinking hypertensive subjects.

Conditions

Interventions

TypeNameDescription
OTHERTeaSingle dose of black tea infusion containing approximately 400 mg flavonoids (expressed as gallic acid equivalents) with added sugar.
OTHERPlaceboPlacebo: tea flavour, colouring and sugar

Timeline

Start date
2014-10-01
Primary completion
2015-10-01
Completion
2015-10-01
First posted
2014-10-23
Last updated
2017-02-15
Results posted
2017-02-15

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT02273323. Inclusion in this directory is not an endorsement.